Alaska Permanent Fund’s Pfizer PFE Stock Holding History

Alaska Permanent Fund’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-42,997	Closed	-$1.05M	–	329
2025 Q1	$1.05M	Hold	42,997	–	–	0.01%	347
2024 Q4	$1.14M	Hold	42,997	–	–	0.02%	354
2024 Q3	$1.24M	Hold	42,997	–	–	0.02%	347
2024 Q2	$1.31M	Buy	42,997 +26,277	+157%	+$723K	0.02%	344
2024 Q1	$464K	Sell	16,720 -88,935	-84%	-$2.47M	0.01%	416
2023 Q4	$3.04M	Sell	105,655 -143,868	-58%	-$4.35M	0.05%	150
2023 Q3	$8.28M	Sell	249,523 -82,121	-25%	-$2.9M	0.16%	76
2023 Q2	$12.2M	Buy	+331,644	New	+$12.9M	0.24%	52
2022 Q4	$12M	Buy	233,390 +20,552	+10%	+$985K	0.2%	36
2022 Q3	$9.31M	Buy	212,838 +29,261	+16%	+$1.42M	0.17%	34
2022 Q2	$9.63M	Buy	183,577 +110,158	+150%	+$5.61M	0.14%	38
2022 Q1	$3.8M	Sell	73,419 -259	-0.4%	-$13.4K	0.06%	42
2021 Q4	$3.88M	Buy	73,678 +8,678	+13%	+$430K	0.07%	31
2021 Q3	$2.8M	Hold	65,000	–	–	0.06%	53
2021 Q2	$2.54M	Buy	+65,000	New	+$2.53M	0.05%	73

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Alaska Permanent Fund's PFE Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Pfizer (PFE) in Q2 2025, closing a stake of 42,997 shares — an estimated $1.05M sold.

Alaska Permanent Fund first reported a position in PFE in Q2 2021 and held it in 15 quarters. The position peaked at $12.2M in Q2 2023. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Alaska Permanent Fund reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Alaska Permanent Fund sold 42,997 Pfizer shares in Q2 2025, an estimated $1.05M.
Alaska Permanent Fund first reported a position in Pfizer in Q2 2021 and held it in 15 quarters.
Alaska Permanent Fund's Pfizer position peaked at $12.2M in Q2 2023.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.